Important Notice: COVID-19

In line with Irish Government efforts to limit the spread of COVID-19 (coronavirus), we will be restricting operations in the PMBRC until the 8^th June 2020 as follows:

• PMBRC staff will be largely working from home over the restricted period. Staff will be available to answer e-mails, write reports and will be working on non-laboratory aspects of projects. However responses to e-mails may be delayed in some cases.
• Laboratory work will be significantly curtailed, although urgent industry work will be carried out where necessary. Please contact Niall O’Reilly on noreilly@wit.ie to arrange this.
• Postgraduate researchers will be working from home.
• Deliveries to the PMBRC should be delayed if possible, particularly if there are special temperature storage requirements.
• Scheduled meetings will be rearranged or conducted remotely where possible.

At the moment these restrictions are in place from the 13^th March to the 8^th June inclusive. However, this period may be extended further depending on Government advice. We thank you for your patience during this time and look forward to returning to normal operations as soon as possible.

Welcome to the PMBRC

The PMBRC is an applied research centre that commenced operations in 2009, consolidating research in the chemical, pharmaceutical and biotechnological sciences at Waterford Institute of Technology into one institutionally prioritised centre. Situated on the main WIT campus in Waterford City, the centre seeks to support R&D activities within the pharmaceutical and healthcare industries, thereby stimulating research and innovation and allowing companies to embed R&D directly into their activities.

The centre, one of 15 Enterprise Ireland Technology Gateways, consists of an 800m² state-of-the-art research facility with over 30 research personnel. A truly multidisciplinary team, researchers at the PMBRC include chemists, biologists, biomedical scientists, physicists and engineers, and the centre has established links with national and international partners in industry, academia and medical care institutions.